Bladder Cancer

Latest News

Sam S. Chang, MD, MBA
Nogapendekin alfa inbakicept shows high CR, avoidance of cystectomy in NMIBC

April 28th 2025

In cohort A, the cystectomy-free rate at 36 months was 84%.

Sandip M. Prasad, MD, MPhil
UGN-102 positions itself as an alternative to TURBT for low-grade NMIBC

April 27th 2025

Blur image of hospital corridor | Image Credit: © jakkapan - stock.adobe.com
Estimated DOR of 2 years is seen with UGN-102 in LG-IR-NMIBC

April 27th 2025

Mark D. Tyson II, MD, MPH
Cretostimogene yields high CR rate in BCG-unresponsive NMIBC

April 27th 2025

Neal D. Shore, MD, FACS
CREST: Significant EFS boost seen with sasanlimab plus BCG in NMIBC

April 26th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.